PRIMARY HYPERHIDROSIS: EPIDEMIOLOGY, PATHOPHYSIOLOGY, CLINICAL FEATURES AND MODERN THERAPEUTIC APPROACHES — LITERATURE REVIEW

Main Article Content

Eshonkhodjaev O.D., Amanov B.B., Yakubov B.F., Bakhromova O.A.

Abstract

Primary hyperhidrosis (PHH) is a chronic disorder characterized by focal, excessive sweating beyond physiological thermoregulatory needs. Although not life-threatening, it significantly impairs quality of life, psychological well-being, and social functioning. This review summarizes current data on epidemiology, etiopathogenesis, clinical presentation, diagnostic criteria, and contemporary therapeutic strategies, including topical, systemic, and procedural interventions.

Article Details

Section

Articles

References

1.Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work-up. J Am Acad Dermatol. 2019;81(3):657–666. doi: 10.1016/j.jaad.2018.12.071.

2.Parveen A, Abbas S, Mehmood N, et al. Primary hyperhidrosis: from a genetics point of view. J Family Med Prim Care. 2023;12(12):3028–3032. doi: 10.4103/jfmpc.jfmpc_1568_22.

3.Schote AB, Schiel F, Schmitt B, et al. Genome-wide linkage analysis of families with primary hyperhidrosis. PLoS One. 2020;15(12):e0244565. doi: 10.1371/journal.pone.0244565.

4.Nastase F, Verenca MC, Niculet E, et al. Primary hyperhidrosis in children: a retrospective study and a short review. Life. 2024;14:645. doi: 10.3390/life14050645.

5.Behinaein P, Gavagan K, Waitzman J, Pourang A, Potts G. A review of the etiologies and key clinical features of secondary hyperhidrosis. Am J Clin Dermatol. 2025;26(1):97–108. doi: 10.1007/s40257-024-00908-6.

6.Collercandy N, Thorey C, Diot E, et al. When to investigate for secondary hyperhidrosis: data from a retrospective cohort of all causes of recurrent sweating. Ann Med. 2022;54(1):2089–2101. doi: 10.1080/07853890.2022.2102675.

7.Aqui TLB, Patel NK, Zhang Y, Kubomoto S. Ipsilateral facial hyperhidrosis in a patient with squamous cell carcinoma of the lung. Cureus. 2022;14(5):e24832. doi: 10.7759/cureus.24832.

8.Arbune M, Iancu AV, Lupasteanu G, et al. A challenge of COVID-19: associated infective endocarditis with Streptococcus gordonii in a young immunocompetent patient. Medicina. 2021;57(12):1298. doi: 10.3390/medicina57121298.

9.Gauer R, Forbes D, Boyer N. Sepsis: diagnosis and management. Am Fam Physician. 2020;101(7):409–418.

10.Luies L, du Preez I. The echo of pulmonary tuberculosis: mechanisms of clinical symptoms and other disease-induced systemic complications. Clin Microbiol Rev. 2020;33(4):e00036–20. doi: 10.1128/CMR.00036-20.

11.Rowane M, Valencia R, Schend J, Jhaveri D, Hostoffer R. Something to sweat about: two cases of dupilumab-induced hyperhidrosis and bromhidrosis. Allergy Rhinol. 2020:11. doi: 10.1177/2152656720927703.

12.Mizukawa Y, Sato Y, Ohyama M, Shiohara T. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab. J Dermatol Sci. 2020;100(1):79–81. doi: 10.1016/j.jdermsci.2020.08.007.